Non-compete restrictions in pharmaceutical foreign investment barred except in special circumstances with government approval. Policy permits full foreign equity in pharmaceuticals for greenfield projects under the automatic route and for brownfield investments under the government approval route; non-compete clauses are disallowed except in special circumstances with prior government approval, and RBI has amended FEMA regulations to implement this clarification.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Non-compete restrictions in pharmaceutical foreign investment barred except in special circumstances with government approval.
Policy permits full foreign equity in pharmaceuticals for greenfield projects under the automatic route and for brownfield investments under the government approval route; non-compete clauses are disallowed except in special circumstances with prior government approval, and RBI has amended FEMA regulations to implement this clarification.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.